Katherine Stitzel and Trevor Waner

Introduction
Toxicol Pathol 1992 20: 469. [PDF] [Request Permission]  

Robert L. Hall

Clinical Pathology for Preclinical Safety Assessment: Current Global Guidelines
Toxicol Pathol 1992 20: 472-476. [Abstract] [PDF] [Request Permission]  

Trevor Waner

Current Statistical Approaches to Clinical Pathological Data from Toxicological Studies
Toxicol Pathol 1992 20: 477-479. [PDF] [References] [Request Permission]  

Michael C. Carakostas

Interpreting Clinical Laboratory Data in Safety Assessment Studies
Toxicol Pathol 1992 20: 480-483. [Abstract] [PDF] [References] [Request Permission]  

Morrow B. Thompson

Clinical Pathology in the National Toxicology Program
Toxicol Pathol 1992 20: 484-489. [Abstract] [PDF] [Request Permission]  

Julia H. Riley

Clinical Pathology: Preanalytical Variation in Preclinical Safety Assessment Studies-Effect on Predictive Value of Analyte Tests
Toxicol Pathol 1992 20: 490-500. [Abstract] [PDF] [References] [Request Permission]  

Dai T. Davies

Enzymology in Preclinical Safety Evaluation
Toxicol Pathol 1992 20: 501-505. [Abstract] [PDF] [References] [Request Permission]  

Michael D. Stonard

Clinical Biochemistry Requirements in the Organization for Economic Cooperation and Development Guidelines — United Kingdom Recommendations
Toxicol Pathol 1992 20: 506-508. [PDF] [Request Permission]  

Judi Weissinger

Clinical Pathology Testing in Preclinical Safety Assessment: Regulatory Concerns
Toxicol Pathol 1992 20: 509-514. [PDF] [References] [Request Permission]  

Hiltje Irausquin

The Value of Clinical Chemistry Data in Animal Screening Studies for Safety Evaluation
Toxicol Pathol 1992 20: 515-518. [PDF] [References] [Request Permission]  

Joy A. Cavagnaro

Regulatory Concerns in the Current Practices of Clinical Pathology
Toxicol Pathol 1992 20: 519-522. [PDF] [References] [Request Permission]  

Penelope Fenner-Crisp

Regulatory Concerns of the United States Environmental Protection Agency
Toxicol Pathol 1992 20: 523-525. [Abstract] [PDF] [References] [Request Permission]  

Rudolf W. Mueller

Thoughts on the Proper Use and Interpretation of Clinical Pathology Data in Preclinical Safety Testing: A Canadian Perspective
Toxicol Pathol 1992 20: 526-527. [PDF] [References] [Request Permission]  

Toshiaki Matsuzawa

Present Status of Animal Clinical Pathology Examinations in the Japanese Pharmaceutical Manufacturers Association
Toxicol Pathol 1992 20: 528-533. [Abstract] [PDF] [References] [Request Permission]  

Jun Kanno

Clinical Pathology Testing Regulatory Concerns
Toxicol Pathol 1992 20: 534-537. [Abstract] [PDF] [References] [Request Permission]  

Kurt W. Weingand

Commentary
Toxicol Pathol 1992 20: 538. [PDF] [Request Permission]  

Kurt Weingand, John Bloom, Michael Carakostas, Robert Hall, Maria Helfrich, Kenneth Latimer, Barry Levine, Douglas Neptun, Alan Rebar, Katherine Stitzel, and Catherine Troup

Clinical Pathology Testing Recommendations for Nonclinical Toxicity and Safety Studies
Toxicol Pathol 1992 20: 539-543. [Abstract] [PDF] [References] [Request Permission]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.